<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03977545</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A02290-55</org_study_id>
    <nct_id>NCT03977545</nct_id>
  </id_info>
  <brief_title>Actigraphy and Neonatal Abstinence Syndrome</brief_title>
  <acronym>ACTINEO</acronym>
  <official_title>Assessment of Actigraphy in the Management of Neonatal Opioid Abstinence Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to analyse the correlation between actigraphy and Lipsitz scoring&#xD;
      system in neonatal opioid abstinence syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neonatal opioid abstinence syndrome occurs after birth when opioids were used by the mother&#xD;
      during pregnancy.&#xD;
&#xD;
      Many scoring systems, like Lipsitz scoring system, are used to diagnose and manage neonatal&#xD;
      abstinence syndrome but they are subjective. The majority of items in these scores are motor&#xD;
      skills items.&#xD;
&#xD;
      Actigraphy allows to measure objectively the newborn motricity. We will analyse the&#xD;
      correlation between actigraphy and Lipsitz scoring system in four groups of newborns.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between actigraphy and Lipsitz scoring system</measure>
    <time_frame>ninety minutes after feeding</time_frame>
    <description>Actigraphy and Lipsitz scoring system are realized at the same time twice a day</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Neonatal Abstinence Syndrome</condition>
  <arm_group>
    <arm_group_label>Newborn with risk of neonatal opioid abstinence syndrome</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eutrophic term newborn</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 2 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term newborn with low birth weight</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 2 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eutrophic premature newborn</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 2 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Actigraphy</intervention_name>
    <description>Actigraphy will be realized twice a day during 30 minutes and Lipsitz scoring system will be realized at the same moment to analyze the correlation between Lipsitz scoring system and actigraphy in each arm.</description>
    <arm_group_label>Eutrophic premature newborn</arm_group_label>
    <arm_group_label>Eutrophic term newborn</arm_group_label>
    <arm_group_label>Newborn with risk of neonatal opioid abstinence syndrome</arm_group_label>
    <arm_group_label>Term newborn with low birth weight</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newborn &gt; 32 weeks of gestation + 0 day&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  perinatal asphyxia&#xD;
&#xD;
          -  5- minute Apgar score &lt; 7&#xD;
&#xD;
          -  ante or post-natal brain injury diagnosis&#xD;
&#xD;
          -  upper arm motor deficit&#xD;
&#xD;
          -  hospitalization in intensive care unit&#xD;
&#xD;
          -  neonatal respiratory distress&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Day</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Elodie LECORPS</last_name>
    <phone>0231272055</phone>
    <email>lecorps-e@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bernard GUILLOIS</last_name>
    <phone>0231272564</phone>
    <email>guillois-b@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Caen Univerity Hospital</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lecorps Elodie</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 5, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neonatal Abstinence Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

